Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 459

1.

GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.

Abs R, Bengtsson BA, Hernberg-Stâhl E, Monson JP, Tauber JP, Wilton P, Wüster C.

Clin Endocrinol (Oxf). 1999 Jun;50(6):703-13.

PMID:
10468941
2.

Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.

Monson JP, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stâhl E, Thorén M, Westberg B, Wilton P, Wüster C.

Clin Endocrinol (Oxf). 2000 Sep;53(3):281-9.

PMID:
10971444
3.

Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.

Feldt-Rasmussen U, Wilton P, Jonsson P; KIMS Study Group; KIMS International Board.

Growth Horm IGF Res. 2004 Jun;14 Suppl A:S51-8.

PMID:
15135778
4.

Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.

Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Góth MI, Koltowska-Häggström M, Monson JP, Verhelst J, Wilton P; KIMS Study Group.

Growth Horm IGF Res. 2005 Oct;15(5):349-59.

PMID:
16168692
5.

Influences on quality of life in GH deficient adults and their effect on response to treatment.

Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Smethurst LE, Shalet SM.

Clin Endocrinol (Oxf). 1999 Nov;51(5):565-73.

PMID:
10594517
6.

A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners.

Davies JS, Obuobie K, Smith J, Rees DA, Furlong A, Davies N, Evans LM, Scanlon MF.

Clin Endocrinol (Oxf). 2000 Mar;52(3):295-303.

PMID:
10718827
7.

Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).

Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.

Growth Horm IGF Res. 2008 Aug;18(4):307-17. doi: 10.1016/j.ghir.2007.12.001. Epub 2008 Feb 20.

PMID:
18282776
8.

The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.

Drake WM, Rodríguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2001 Apr;54(4):525-32.

PMID:
11318789
9.

Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database.

Kreitschmann-Andermahr I, Poll EM, Reineke A, Gilsbach JM, Brabant G, Buchfelder M, Fassbender W, Faust M, Kann PH, Wallaschofski H.

Growth Horm IGF Res. 2008 Dec;18(6):472-8. doi: 10.1016/j.ghir.2008.08.007. Epub 2008 Oct 1.

PMID:
18829359
10.

The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database.

Spielhagen C, Schwahn C, Möller K, Friedrich N, Kohlmann T, Moock J, Kołtowska-Häggström M, Nauck M, Buchfelder M, Wallaschofski H.

Growth Horm IGF Res. 2011 Feb;21(1):1-10. doi: 10.1016/j.ghir.2010.10.005. Epub 2010 Nov 19.

PMID:
21093334
11.

Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.

Schneider HJ, Oertel H, Murck H, Pollmächer T, Stalla GK, Steiger A.

Psychoneuroendocrinology. 2005 Jan;30(1):29-37.

PMID:
15358440
12.

Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.

Svensson J, Mattsson A, Rosén T, Wirén L, Johannsson G, Bengtsson BA, Koltowska Häggström M; Swedish KIMS National Board.

Growth Horm IGF Res. 2004 Jun;14(3):207-15.

PMID:
15125882
13.

Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects.

Malik IA, Foy P, Wallymahmed M, Wilding JP, MacFarlane IA.

Clin Endocrinol (Oxf). 2003 Jul;59(1):75-81.

PMID:
12807507
14.

Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities.

Abdu TA, Neary R, Elhadd TA, Akber M, Clayton RN.

Clin Endocrinol (Oxf). 2001 Aug;55(2):209-16. Erratum in: Clin Endocrinol (Oxf) 2001 Nov;55(5):699.

PMID:
11531927
15.

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.

Florakis D, Hung V, Kaltsas G, Coyte D, Jenkins PJ, Chew SL, Grossman AB, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2000 Oct;53(4):453-9.

PMID:
11012570
16.

Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects.

Li Voon Chong JS, Benbow S, Foy P, Wallymahmed ME, Wile D, MacFarlane IA.

Clin Endocrinol (Oxf). 2000 Nov;53(5):551-9.

PMID:
11106915
17.

Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults.

Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Shalet SM.

Clin Endocrinol (Oxf). 1999 Jun;50(6):749-57.

PMID:
10468947
18.

Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.

Beshyah SA, Freemantle C, Shahi M, Anyaoku V, Merson S, Lynch S, Skinner E, Sharp P, Foale R, Johnston DG.

Clin Endocrinol (Oxf). 1995 Jan;42(1):73-84.

PMID:
7889635
19.

Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.

Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP.

Clin Endocrinol (Oxf). 2001 Jun;54(6):709-17.

PMID:
11422104
20.

Supplemental Content

Support Center